Biotech entity

United States

government

Every one of those 2 sits in a single category, pharma. Of the tracked stories, 1 of 2 also mention China, the most common co-covered peer. Across a 20-day span, the pace is roughly 0.7 stories per week. The 7.5 average consequence score is above the beat benchmark of 6 in the same window.

Last mentioned: Jul 10, 2026

Entity pulse

Recent coverage · United States

2 stories
7.5 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about United States

Every one of those 2 sits in a single category, pharma. Of the tracked stories, 1 of 2 also mention China, the most common co-covered peer. Across a 20-day span, the pace is roughly 0.7 stories per week. The 7.5 average consequence score is above the beat benchmark of 6 in the same window. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. United States appears in 2 tracked Biotech stories published from February 21, 2026 through March 12, 2026.

Stories tracked
2
Per week
0.7
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 225 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering United States. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Strategic Target

    Deadline for China to become the primary global exporter of medical technology standards.

  2. Leadership Mandate

    New policy shift explicitly targets global leadership over 'catching up' with Western tech.

  3. Ministerial Warning

    Health Minister José Ángel Portal Miranda warns of a looming humanitarian crisis in an AP interview.

  4. Logistical Collapse

    Ambulance services and medical supply flights begin widespread suspensions due to lack of fuel.

  5. U.S. Executive Order

    President Trump signs order imposing tariffs on any nation providing oil to the Cuban government.

  6. Venezuelan Oil Cutoff

    U.S. announces end of Venezuelan oil shipments to Cuba following political shifts in Caracas.

  7. Patent Milestone

    China surpasses the US in total international patent filings for CRISPR and AI-drug discovery.

  8. 14th Five-Year Plan

    China emphasizes 'self-reliance' and domestic technology loops.

Stories mentioning United States 2

Pharma Neutral

China Signals Global Dominance in Biotech via New Strategic Roadmap

China’s latest strategic roadmap shifts from a 'catch-up' posture to a mandate for global leadership in frontier technologies. This pivot places biotechnology and genomic medicine at the center of national security and economic growth, challenging decades of U.S. dominance in drug innovation.

2 sources
Pharma Strongly negative

US Fuel Blockade Pushes Cuba’s Healthcare System to the Brink of Collapse

A severe energy crisis triggered by intensified U.S. sanctions and a fuel blockade has brought Cuba's healthcare infrastructure to a near-total standstill. With hospitals facing persistent power outages and ambulances grounded by fuel shortages, the island is facing an unprecedented humanitarian emergency.

2 sources

United States is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.